tolperisone has been researched along with Parkinsonian Disorders in 1 studies
Tolperisone: A centrally acting muscle relaxant that has been used for the symptomatic treatment of spasticity and muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1211)
Parkinsonian Disorders: A group of disorders which feature impaired motor control characterized by bradykinesia, MUSCLE RIGIDITY; TREMOR; and postural instability. Parkinsonian diseases are generally divided into primary parkinsonism (see PARKINSON DISEASE), secondary parkinsonism (see PARKINSON DISEASE, SECONDARY) and inherited forms. These conditions are associated with dysfunction of dopaminergic or closely related motor integration neuronal pathways in the BASAL GANGLIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BLONDEL, F | 1 |
| COULEON, M | 1 |
| COULEON, H | 1 |
| ANNE, L | 1 |
| CLERC, G | 1 |
| COULOMBIER, J | 1 |
1 other study available for tolperisone and Parkinsonian Disorders
| Article | Year |
|---|---|
[MYDOCALM TREATMENT OF PSEUDO-PARKINSON DISORDERS FOLLOWING THE ADMINISTRATION OF NEUROLEPTIC AGENTS].
Topics: Antipsychotic Agents; Drug Therapy; Parasympatholytics; Parkinson Disease; Parkinsonian Disorders; P | 1964 |